INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades
$4.26M
  • 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  • 06SJSheena Jonathan0B / 43S43 trades$3.14M
  • 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  • 08RJRubinstein Julie0B / 37S37 trades$6.25M
  • 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  • 10RARothblatt Martine A0B / 33S33 trades$5.50M
  • Form 4 transactions

    21,973 records
    Side
    allbuysell
    Score
    any≥ 30≥ 50≥ 70
    Sort
    Newest disclosedNewest executedInsider ScoreValue
    Include
    grants & admin
    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    41
    PJ
    Phelan Kenneth JDirector
    HPFJOHN HANCOCK PREFERRED INCOME FUND II
    Open-market purchase
    BUY$10K
    618 sh
    Jan 26, 2026
    Page 411 of 550
    ← PrevNext →
    Jan 27, 2026
    traded Jan 26, 2026
    +1d
    SEC Form 4

    Evidence

    41
    PJ
    Phelan Kenneth JDirector
    HEQJohn Hancock Diversified Income Fund
    Open-market purchase
    BUY$10K
    905 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    41
    FG
    Freve Maria GSee Remarks
    SYMSymbotic Inc.
    Open-market sale
    SELL$400K
    6,667 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$133K
    144 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    Ruemmler Kathryn H.Chief Legal Officer, GC
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$167K
    178 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$71K
    76 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    HC
    Halio CareyGlobal Treasurer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$126K
    136 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    HC
    Halio CareyGlobal Treasurer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$233K
    252 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$115K
    124 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$192K
    208 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    HC
    Halio CareyGlobal Treasurer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$135K
    146 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    HC
    Halio CareyGlobal Treasurer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$172K
    187 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    HC
    Halio CareyGlobal Treasurer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$241K
    262 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    Ruemmler Kathryn H.Chief Legal Officer, GC
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$56K
    60 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$155K
    167 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    39
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$81K
    87 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    37
    PJ
    Phelan Kenneth JDirector
    JHSJOHN HANCOCK INCOME SECURITIES TRUST
    Open-market purchase
    BUY$8,541
    725 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    36
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$37K
    40 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    36
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$11K
    12 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    36
    FJ
    Fredman Sheara JChief Accounting Officer
    GSGOLDMAN SACHS GROUP INC
    Open-market sale
    SELL$9,360
    10 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    36
    AK
    Alam KamranCHIEF FINANCIAL OFFICER
    TSHATaysha Gene Therapies, Inc.
    Open-market sale
    SELL$375K
    79.0K sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    34
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale
    SELL$81K
    842 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    33
    WL
    Whitley Laura LDirector
    TCBITEXAS CAPITAL BANCSHARES INC/TX
    Open-market purchase
    BUY$49K
    500 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    33
    BK
    Banks Margaret KatherineDirector
    HALHALLIBURTON CO
    Open-market sale
    SELL$89K
    2,600 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    32
    NS
    Nagendran SukumarDirector, President and Head of R&D
    TSHATaysha Gene Therapies, Inc.
    Open-market sale
    SELL$423K
    89.1K sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    30
    WF
    Walsh John FCEO-The Americas
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$718K
    2,600 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    30
    KJ
    Kuffner JamesCHIEF TECHNOLOGY OFFICER
    SYMSymbotic Inc.
    Open-market sale
    SELL$63K
    1,048 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    29
    WL
    Whitley Laura LDirector
    TCBITEXAS CAPITAL BANCSHARES INC/TX
    Open-market purchase
    BUY$49K
    500 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    25
    AK
    Alam KamranCHIEF FINANCIAL OFFICER
    TSHATaysha Gene Therapies, Inc.
    Open-market sale
    SELL$110K
    23.8K sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    25
    NS
    Nagendran SukumarDirector, President and Head of R&D
    TSHATaysha Gene Therapies, Inc.
    Open-market sale
    SELL$124K
    26.9K sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    24
    DM
    Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
    TVTXTravere Therapeutics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$1.56M
    51.9K sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    23
    WF
    Walsh John FCEO-The Americas
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$119K
    429 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    23
    WF
    Walsh John FCEO-The Americas
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$144K
    524 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    23
    WF
    Walsh John FCEO-The Americas
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$117K
    421 sh
    Jan 27, 2026Jan 27, 2026
    traded Jan 27, 2026
    +0dSEC Form 4

    Evidence

    23
    HK
    Hogan Catherine KiernanChief Operating Officer
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$64K
    227 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    23
    HK
    Hogan Catherine KiernanChief Operating Officer
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$74K
    263 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    22
    A
    A-6684 Ltd.10% Owner
    TOFBTOFUTTI BRANDS INC
    Open-market purchase
    BUY$3,439
    4,525 sh
    Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    +4dSEC Form 4

    Evidence

    20
    HK
    Hogan Catherine KiernanChief Operating Officer
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$283
    1 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    20
    HK
    Hogan Catherine KiernanChief Operating Officer
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$30K
    107 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence

    20
    HK
    Hogan Catherine KiernanChief Operating Officer
    ACNAccenture plc
    Open-market sale · 10b5-1 plan
    SELL$17K
    62 sh
    Jan 26, 2026Jan 27, 2026
    traded Jan 26, 2026
    +1dSEC Form 4

    Evidence